Ingredients

Aging + Actives

Featured Aging + Actives

Clean Preservatives

Featured Clean Preservatives

Bioactive Botanicals

Featured Bioactive Botanicals

Functional + Sensory

Featured Functional + Sensory

TeraBiome™

TeraFluid™ Light

TeraGel™

Formulation
Library

Our Favorite Formulations

Services

Custom Formulation

Dermatology Advisory & Innovation

Documents
Learn
About Us
Scientific
Papers
Adapinoid Report Cover
Happy smiling cheerful excited satisfied grey-haired senior mother and brunette young daughter holding hand and hugging with love tenderness closeup studio portrait. Different age generation bonding

Adapinoid®

Adapinoid® vs. Retinol
Download clinical results
TXV_Journal-of-Cosmetic-Dermatology
NewTXVModel

TXVector™

TXVector™ Safety and Skin-Lightening Performance Results
Download clinical results
TXV_PDF_Page-01
NewTXVModel

TXVector™

TXVector™ Skin Penetration Results
Download clinical results
Salixin-Dandruff-Paper_Clinical-Cosmetic-and-Investigational-Dermatology-copy_Page_01
Salix2

Salixin®

The Treatment and Evaluation of Dandruff and Scalp Erythema with Fermented Salix purpurea Bark Extract
Download clinical results
Partners
Sustainably and renewably sourced purple will bark extract which contains healing salicylates and polyphenols 
High performance keratin derived actives for hair & scalp repair
Advanced bioprocessing and sustainable sourcing of therapeutic fucoidan from seaweed
Virgin oil and extracts with unique protective properties from the Arabian Peregrina tree
Contact
Prior Art Formulations

TXV Sensitive Rich

LP-1583

Aqua (Water)Q.S. to 100
Isocetyl Stearate1–7%
Coco-Caprylate/Caprate1–20%
Squalane1–5%
Butyrospermum Parkii Butter/Shea Butter1–25%
Glycerin1–5%
Propanediol1–5%
Cetyl Alcohol1–5%
Aluminum Starch Octenylsuccinate1–5%
Glyceryl Stearate1–7%
Pentylene Glycol1–5%
PEG-100 Stearate1–7%
Niacinamide0.2–5%
Cetearyl Alcohol1–5%
Sodium Hydroxide0.1–1%
Caprylyl Glycol1–5%
Citric Acid0.1–1%
Acrylates/C10-30 Alkyl Acrylate Crosspolymer0.1–1%
Cetyl Tranexamate Mesylate0.001–8%
BACK TO PRIOR ART FORMULATIONS